4fuj: Difference between revisions

(6 intermediate revisions by the same user not shown)

Line 1:

~~'''Unreleased structure'''~~

The ~~entry 4fuj~~ is ~~ON HOLD until Paper Publication~~

==Crystal Structure of the Urokinase==

== Structural highlights ==

<table><tr><td colspan='2'>[[4fuj]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4FUJ OCA]. For a guided tour on the structure components use [https://proteopedia.org/fgij/fg.htm?mol=4FUJ FirstGlance].

</td></tr><tr id='method'><td class="sblockLbl">[[Empirical_models|Method:]]</td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.05Å</td></tr>

<tr id='ligand'><td class="sblockLbl">[[Ligand|Ligands:]]</td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1U9:6-{(E)-2-[3-(2-HYDROXYETHYL)PHENYL]ETHENYL}NAPHTHALENE-2-CARBOXIMIDAMIDE'>1U9</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SIN:SUCCINIC+ACID'>SIN</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>

<tr id='resources'><td class="sblockLbl">Resources:</td><td class="sblockDat">[https://proteopedia.org/fgij/fg.htm?mol=4fuj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4fuj OCA], [https://pdbe.org/4fuj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4fuj RCSB], [https://www.ebi.ac.uk/pdbsum/4fuj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4fuj ProSAT]</td></tr>

</table>

== Disease ==

[https://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN] Defects in PLAU are the cause of Quebec platelet disorder (QPD) [MIM:[https://omim.org/entry/601709 601709]. QPD is an autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins.<ref>PMID:20007542</ref>

== Function ==

[https://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN] Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.

~~Authors~~: Kang~~, Y.N., Stuckey, J.A.,~~ Nienaber~~, V., Giranda,~~ V.

==See Also==

*[[Urokinase 3D Structures|Urokinase 3D Structures]]

~~Description~~: ~~Crystal Structure of the Urokinase~~

== References ==

__TOC__

</StructureSection>

[[Category: Homo sapiens]]

[[Category: Large Structures]]

[[Category: Giranda V]]

[[Category: Kang YN]]

[[Category: Nienaber V]]

[[Category: Stuckey JA]]

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
-The entry 4fuj is ON HOLD  until Paper Publication
+==Crystal Structure of the Urokinase==
+<StructureSection load='4fuj' size='340' side='right'caption='[[4fuj]], [[Resolution|resolution]] 2.05&Aring;' scene=''>
+== Structural highlights ==
+<table><tr><td colspan='2'>[[4fuj]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4FUJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4FUJ FirstGlance]. <br>
+</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.05&#8491;</td></tr>
+<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1U9:6-{(E)-2-[3-(2-HYDROXYETHYL)PHENYL]ETHENYL}NAPHTHALENE-2-CARBOXIMIDAMIDE'>1U9</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SIN:SUCCINIC+ACID'>SIN</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4fuj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4fuj OCA], [https://pdbe.org/4fuj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4fuj RCSB], [https://www.ebi.ac.uk/pdbsum/4fuj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4fuj ProSAT]</span></td></tr>
+</table>
+== Disease ==
+[https://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN] Defects in PLAU are the cause of Quebec platelet disorder (QPD) [MIM:[https://omim.org/entry/601709 601709]. QPD is an autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins.<ref>PMID:20007542</ref>
+== Function ==
+[https://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN] Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.
-Authors: Kang, Y.N., Stuckey, J.A., Nienaber, V., Giranda, V.
+==See Also==
+*[[Urokinase 3D Structures|Urokinase 3D Structures]]
-Description: Crystal Structure of the Urokinase
+== References ==
+<references/>
+__TOC__
+</StructureSection>
+[[Category: Homo sapiens]]
+[[Category: Large Structures]]
+[[Category: Giranda V]]
+[[Category: Kang YN]]
+[[Category: Nienaber V]]
+[[Category: Stuckey JA]]